BRAF V600E MUTATIONS IN METASTATIC MELANOMA - CASE REPORT

The treatment of metastatic melanoma represents a challenge. Vemurafenib, a selective BRAF kinase inhibitor, is a new medicine against carcinoma. Recently, it has been shown that it raises the survival rate among patients with metastatic melanoma who have BRAFV600mutation. This work will discuss new...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ivana Inić, Momcilo Inić, Zorka Inić, Milan Zegarac, Aleksandar Martinović, Miomir Šašić, Miloš Bracanović, Gordana Pupić
Formato: Artigo
Idioma:Inglês
Publicado em: University in Nis, Faculty of Medicine 2014-09-01
Colecção:Acta Medica Medianae
Assuntos:
metastatic melanoma
BRAF V600 mutation
treatment
Acesso em linha:http://publisher.medfak.ni.ac.rs/2014-html/3-broj/Ivana%20Inic-BRAF.pdf
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados